Prenatal and Newborn Genetic Testing Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Prenatal and Newborn Genetic Testing Market to 2027 - Global Analysis and Forecasts By Product (Diagnostic, and Screening), Disease (Cystic Fibrosis, Sickle Cell Anemia, Downs Syndrome, Phenylketonuria, and Other Disease), End User (Hospitals & Clinics, Diagnostic Centers, and Other End User) and Geography

Report Code: TIPBT00002550 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Prenatal genetic testing is performed during the pregnancy for the diagnosis of the diseases or detection of certain genetic abnormalities before 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Most prenatal genetic tests are completed by drawing a blood sample from the mother. Diagnostic methods are more effective, accurate and a preferred option for the detection of chromosome abnormalities as compared to the screening methods.

The market of prenatal and newborn genetic testing is anticipated to grow with a significant rate in the coming years, owing to factors such as faster increase in genetic abnormalities, rise in fetal mortality, and advancement of healthcare technologies are driving the prenatal and newborn genetic testing market. Moreover, increase in adoption of new technologies such as non-invasive prenatal testing (NIPT) and non-invasive cell-free fetal DNA-based screening in the developed regions, for early detection of births defects will foster market growth opportunities in the prenatal and newborn genetic testing market.

The "Global Prenatal and Newborn Genetic Testing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global prenatal and newborn genetic testing market trend. The report aims to provide an overview of global prenatal and newborn genetic testing market with detailed market segmentation by product, disease, end-user, and geography. The global prenatal and newborn genetic testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the prenatal and newborn genetic testing market.

The global prenatal and newborn genetic testing market is segmented on the basis of product, disease, and end-user. The product segment includes diagnostic, and screening. The segment of diagnostic is further classified into, spectrophotometer, polymerase chain reaction, fluorescence in-situ hybridization, and array-comparative genomic hybridization. On the screening basis market is segmented as, maternal serum screening, chorionic villus sampling, amniocentesis, and non-invasive prenatal testing. Based on disease, the prenatal and newborn genetic testing market is segmented as, cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria, and other disease. Based on end user, the market is classified as, hospitals & clinics, diagnostic centers, and other end user.

The prenatal and newborn genetic testing market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global prenatal and newborn genetic testing market based on product, disease, and end-user. It also provides market size and forecast till 2027 for overall prenatal and newborn genetic testing market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prenatal and newborn genetic testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to be the largest contributor in the overall revenue generation in prenatal and newborn genetic testing market, due to favorable government policies towards proper diagnosis and screening of genetic abnormalities and the presence of advanced technological advancements and rising benefits in the field of prenatal testing and newborn genetic screening in North America. However, Asia-Pacific prenatal and newborn genetic testing market is expected to show lucrative growth during the forecast period, with the majority of growth primarily driven by presence of government initiatives supporting screening activities that will impel market growth. Moreover, increase in the number of medical institutions and facilities providing prenatal and new-born genetic testing will expand the industry growth in forthcoming years.

The prenatal and newborn genetic testing market report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key prenatal and newborn genetic testing manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Abbott, Oxford Gene Technology, Ravgen, Bio-Rad Laboratories, Inc., Illumina, Inc., SOPHiA GENETICS, PerkinElmer Inc., SEBIA, Sequenom, and Natera, Inc. among the others.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. PRENATAL AND NEWBORN GENETIC TESTING MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Prenatal and Newborn Genetic Testing Market - By Product
3.2.2. Prenatal and Newborn Genetic Testing Market - By Disease
3.2.3. Prenatal and Newborn Genetic Testing Market - By End User
3.2.4. Prenatal and Newborn Genetic Testing Market - By Region
3.2.4.1. By Country

4. PRENATAL AND NEWBORN GENETIC TESTING MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. PRENATAL AND NEWBORN GENETIC TESTING MARKET - GLOBAL ANALYSIS
5.1. GLOBAL PRENATAL AND NEWBORN GENETIC TESTING MARKET OVERVIEW
5.2. GLOBAL PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
6. PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. DIAGNOSTIC MARKET
6.3.1. Overview
6.3.2. Diagnostic Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Spectrophotometer Market
6.3.3.1. Overview
6.3.3.2. Spectrophotometer Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Polymerase Chain Reaction Market
6.3.4.1. Overview
6.3.4.2. Polymerase Chain Reaction Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Fluorescence In-Situ Hybridization Market
6.3.5.1. Overview
6.3.5.2. Fluorescence In-Situ Hybridization Market Revenue Forecasts and Analysis (US$ Mn)
6.3.6. Array-Comparative Genomic Hybridization Market
6.3.6.1. Overview
6.3.6.2. Array-Comparative Genomic Hybridization Market Revenue Forecasts and Analysis (US$ Mn)
6.4. SCREENING MARKET
6.4.1. Overview
6.4.2. Screening Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3. Maternal Serum Screening Market
6.4.3.1. Overview
6.4.3.2. Maternal Serum Screening Market Revenue Forecasts and Analysis (US$ Mn)
6.4.4. Chorionic Villus Sampling Market
6.4.4.1. Overview
6.4.4.2. Chorionic Villus Sampling Market Revenue Forecasts and Analysis (US$ Mn)
6.4.5. Amniocentesis Market
6.4.5.1. Overview
6.4.5.2. Amniocentesis Market Revenue Forecasts and Analysis (US$ Mn)
6.4.6. Non-Invasive Prenatal Testing Market
6.4.6.1. Overview
6.4.6.2. Non-invasive prenatal testing Market Revenue Forecasts and Analysis (US$ Mn)

7. PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY DISEASE
7.1. OVERVIEW
7.2. DISEASE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. CYSTIC FIBROSIS MARKET
7.3.1. Overview
7.3.2. Cystic Fibrosis Market Revenue Forecasts and Analysis (US$ Mn)
7.4. SICKLE CELL ANEMIA MARKET
7.4.1. Overview
7.4.2. Sickle Cell Anemia Market Revenue Forecasts and Analysis (US$ Mn)
7.5. DOWNS SYNDROME MARKET
7.5.1. Overview
7.5.2. Downs Syndrome Market Revenue Forecasts and Analysis (US$ Mn)
7.6. PHENYLKETONURIA MARKET
7.6.1. Overview
7.6.2. Phenylketonuria Market Revenue Forecasts and Analysis (US$ Mn)
7.7. OTHERS MARKET
7.7.1. Overview
7.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

8. PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS & CLINICS MARKET
8.3.1. Overview
8.3.2. Hospitals & Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. DIAGNOSTIC CENTERS MARKET
8.4.1. Overview
8.4.2. Diagnostic Centers Market Revenue Forecasts and Analysis (US$ Mn)
8.5. OTHER END USER MARKET
8.5.1. Overview
8.5.2. Other End User Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA PRENATAL AND NEWBORN GENETIC TESTING MARKET OVERVIEW
9.2. NORTH AMERICA PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.3.1. North America Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
9.3.2. North America Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
9.4. NORTH AMERICA PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
9.5. NORTH AMERICA PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.1.1. US Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
9.7.1.2. US Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
9.7.2. US Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
9.7.3. US Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)

9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.1.1. Canada Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
9.8.1.2. Canada Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
9.8.2. Canada Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
9.8.3. Canada Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.9.1.1. Mexico Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
9.9.1.2. Mexico Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
9.9.2. Mexico Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
9.9.3. Mexico Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)

10. EUROPE PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE PRENATAL AND NEWBORN GENETIC TESTING MARKET OVERVIEW
10.2. EUROPE PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.3.1. Europe Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
10.3.2. Europe Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
10.4. EUROPE PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
10.5. EUROPE PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

10.7. UK MARKET OVERVIEW
10.7.1. UK Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.1.1. UK Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
10.7.1.2. UK Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
10.7.2. UK Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.7.3. UK Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.1.1. Germany Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
10.8.1.2. Germany Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
10.8.2. Germany Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.8.3. Germany Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.1.1. France Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
10.9.1.2. France Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
10.9.2. France Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.9.3. France Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. ASIA PACIFIC PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC PRENATAL AND NEWBORN GENETIC TESTING MARKET OVERVIEW
11.2. ASIA PACIFIC PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.3.1. Asia Pacific Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
11.3.2. Asia Pacific Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
11.4. ASIA PACIFIC PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
11.5. ASIA PACIFIC PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. JAPAN MARKET OVERVIEW
11.7.1. Japan Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.1.1. Japan Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
11.7.1.2. Japan Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
11.7.2. Japan Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.7.3. Japan Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. CHINA MARKET OVERVIEW
11.8.1. China Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.1.1. China Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
11.8.1.2. China Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
11.8.2. China Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.8.3. China Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.1.1. India Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
11.9.1.2. India Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
11.9.2. India Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.9.3. India Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) PRENATAL AND NEWBORN GENETIC TESTING MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) (MEA) PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.3.1. Middle East and Africa (MEA) Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
12.3.2. Middle East and Africa (MEA) Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
12.4. MIDDLE EAST AND AFRICA (MEA) PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.7.1.1. South Africa Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
12.7.1.2. South Africa Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
12.7.2. South Africa Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.7.3. South Africa Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.1.1. Saudi Arabia Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
12.8.1.2. Saudi Arabia Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
12.8.2. Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.8.3. Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.1.1. UAE Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
12.9.1.2. UAE Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
12.9.2. UAE Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.9.3. UAE Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. SOUTH AND CENTRAL AMERICA PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL PRENATAL AND NEWBORN GENETIC TESTING MARKET OVERVIEW
13.2. SOUTH AND CENTRAL PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.3.1. South and Central Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
13.3.2. South and Central Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
13.4. SOUTH AND CENTRAL PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
13.5. SOUTH AND CENTRAL PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL PRENATAL AND NEWBORN GENETIC TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.7.1.1. Brazil Diagnostic Market Revenue Forecast and Analysis - By Type (US$ Mn)
13.7.1.2. Brazil Screening Market Revenue Forecast and Analysis - By Type (US$ Mn)
13.7.2. Brazil Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.7.3. Brazil Prenatal and Newborn Genetic Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
14.2.3. Geographic Expansions

15. PRENATAL AND NEWBORN GENETIC TESTING MARKET, KEY COMPANY PROFILES
15.1. ABBOTT
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. OXFORD GENE TECHNOLOGY
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. RAVGEN
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. BIO-RAD LABORATORIES, INC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. ILLUMINA, INC.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. SOPHiA GENETICS
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Product Portfolio
15.6.4. SWOT Analysis
15.6.5. Key Developments
15.7. PERKINELMER INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. SEBIA
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. SEQUENOM
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. NATERA, INC.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. SWOT Analysis
15.10.6. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Abbott
2. Oxford Gene Technology
3. Ravgen.
4. Bio-Rad Laboratories, Inc.
5. Illumina, Inc.
6. SOPHiA GENETICS
7. PerkinElmer Inc.
8. SEBIA
9. Sequenom.
10. Natera, Inc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book